New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
Advertisement

Portfolio Building Block World Pharma and Biotech Index ETF

This ETF provides exposure to Large Cap Developed markets Equities

PBPH performance and flow charts

Last update 9/11/2026 at 1:30 PM
Live
Closed
Last price
$27.80
-$0.04 (-0.15%) 9/11/2026

Performance

-2.00.02.04.06.0%Aug 11Aug 18Aug 26Sep 2Sep 9

Flows

0 M10 M20 M30 M40 M
1 day price range
$27.79
$28.04
52 week price range
$24.21
$29.72
1W perf
-4.16%
YTD perf
+10.08%
YTD flows
+$968M
AuM
$1.01B
E/R
0.13%
TTM yield
-
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

Historic performance and flows

Data as of September 11, 2026
1M3MYTD1Y3Y5Y
Perf.-0.72%+7.13%+10.08%
Flows+$35M+$139M+$968M---
Data as of September 11, 2026
Advertisement

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Characteristics

The Portfolio Building Block World Pharma and Biotech Index ETF is built to track the BITA Global Pharma and Biotech Select GRT Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.

Management strategyPassive
StrategyLong Only
ProviderTidal
N° of holdings53
Replication methodDirect (Physical)
Asset classEquity
Dividend policyDistributing
Inception dateNovember 24, 2025
ESGNo
TrackinsightTrackinsight

More data and info about PBPH on Trackinsight

Exposure

Data as of July 31, 2026

Diversification

75.4%

Total weight of top 15 holdings out of 53

Top 15 Holdings

Eli Lilly & Co.
15.14%
Johnson & Johnson
9.55%
AbbVie, Inc.
7.06%
Merck & Co., Inc.
4.97%
Roche Holding AG
4.7%
Amgen, Inc.
4.62%
Novartis AG
4.45%
AstraZeneca PLC
3.88%
Gilead Sciences, Inc.
3.77%
Novo Nordisk A/S
3.75%
Pfizer Inc.
3.28%
Bristol Myers Squibb Co.
3.06%
Vertex Pharmaceuticals, Inc.
2.82%
GSK Plc
2.24%
Sanofi
2.1%

Sectors

Healthcare
99.46%
Other
0.54%

Countries

USA
65.24%
Switzerland
10.52%
United Kingdom
7.15%
Other
17.09%
Advertisement

Trading data

Last sale
9/11/2026 at 1:30 PM
$27.80
Previous close
$27.85
Consolidated volume
09/11/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

Volatility and drawdown

3M1Y3Y5Y
Volatility+20.50%
Max drawdown
-6.59%
Max drawdown duration
17dN/AN/AN/A
Time to recover
N/AN/AN/AN/A

Replication quality

Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free
Tracking error
Join for free
Tracking difference
Join for free
1 year cumulative return difference
Best
Join for free
Worst
Join for free
daily return difference
Average
Join for free
Worst
Join for free
Advertisement
Frequently asked questions about PBPH

What type of ETF is PBPH?

PBPH is a Passive ETF that provides exposure to Equity assets. It is managed by Tidal.

What index does PBPH track?

PBPH tracks the BITA Global Pharma and Biotech Select GRT Index - USD, aiming to replicate its performance through full replication.

What does PBPH invest in?

This ETF provides exposure to Large Cap Developed markets Equities. It is part of the segment: DM Large & Mid Cap.

What is the expense ratio of PBPH?

The total expense ratio (TER) of PBPH is 0.13%, representing the annual fee charged by the fund manager.

When was PBPH launched?

PBPH was launched on November 24, 2025, marking its entry into the ETF market.

Who is the issuer of PBPH?

PBPH is issued by Tidal.

What is the AUM of PBPH?

As of September 11, 2026, PBPH manages $1.01 B, reflecting the total assets held in the fund.

How has PBPH performed recently?

As of September 11, 2026, PBPH delivered a return of -0.72% over the past month (1M performance), 7.13% over the past three months (3M), and 10.08% year-to-date (YTD).

What are the recent fund flows for PBPH?

As of September 11, 2026, PBPH has seen net flows of +$35M in the past month (1M flow) and +$968M year-to-date (YTD).

How many holdings are in PBPH

As of July 31, 2026, PBPH holds 53 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.

How diversified is PBPH?

As of July 31, 2026, PBPH holds 53 securities, with 75.4% of its assets concentrated in its top 15 holdings.

What are the top holdings of PBPH?

As of July 31, 2026, PBPH holds a portfolio of 53 underlyings, with its largest positions including Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. These top holdings play a significant role in shaping the fund’s performance and exposure.

What countries or regions does PBPH invest in?

As of July 31, 2026, PBPH has its largest geographic exposures in USA, Switzerland and United Kingdom.

What sectors or themes does PBPH focus on?

As of July 31, 2026, PBPH is primarily exposed to Healthcare.

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

ETF Institute
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides
Advertisement

Recent educational content

Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs September 8, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 9, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs August 31, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 1, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs August 24, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · August 24, 2026
What's the Fund | Ocean Park Diversified Income ETF (DUKZ)

What’sTheFund

What's the Fund | Ocean Park Diversified Income ETF (DUKZ)

James St Aubin, Chief Investment Officer at Ocean Park Asset Management, discuss the DUKZ ETF, exposing investors to the whole spectrum of asset classes in the fixed income markets, through their rules-based process.

NYSE logo
By NYSE · August 18, 2026

Browse all educational columns

Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder